Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Int J Urol. 2015 Nov 30;23(3):211–218. doi: 10.1111/iju.13016

Table 3.

Criteria for progression used in AS protocol

Protocol Gleason Positive Cores Percentage of Core Affected PSADT
Tosoian et al. (15) >6 >2 >50
Klotz et al. (16) >4+3 <3
Dall'Era et al. (18) Increase
Soloway et al. (21) >3+3 >2
Thomsen et al. (63) ≥4+3 >3 <3/5

Abbreviation: PSADT = prostate-specific antigen doubling time